tamsulosin 0.8 mg
reassurance
repeat total and free PSA
diagnostic cystoscopy
C. repeat total and free PSA
each centimeter over the normal 2-cm prostate urethral length equates
an additional 12 g in prostate weight
each centimeter over the normal 2.5-cm prostate urethral length equates
an additional 10 g in prostate weight
tamsulosin 0.8 mg
reassurance
repeat total and free PSA
diagnostic cystoscopy
symptoms begin with a serum sodium of less than 120 mEq/L
the mortality is 2.7-5.8 %
manifestations rely on acute changes in the intravascular volume and plasma solute concentrations
the preferred height of irrigating fluid is 60 cm above the patient
2 weeks after performing prostatic urethral lift
6-month treatment with 5α-reductase inhibitors
after placing a stent in the prostatic urethra
immediately after removing one-half of the prostate by TURP
LUTS with neurologic disease
LUTS with post-void dribble
LUTS with suspicious DRE
LUTS with hematuria
0.2 1%
1.2 2.1%
2.3 3.4%
3.7 5.6%
tamsulosin
alfuzosin
doxazosin
silodosin
hematuria and infections
migration and encrustation of the stent
irritative urinary symptoms and painful ejaculation
all of the above
alfuzosin
silodosin
finasteride
tamsulosin
IPSS cannot be used to establish the diagnosis of BPH/LUTS
prostate biopsy is essential in diagnosing BPH and excluding cancers
PSA and uroflowmetry help diagnose the condition
none of the above
prostate sizes of up to 70 ml can be treated
not recommended in patients with metallic artificial hip
retreatment rates are lower than for TURP
can be performed in an office-based setting
men with storage symptoms
men with ED
failed combination of α-adrenergic blocker and 5α-reductase inhibitor
a & b
is only indicated in small prostates
complications are related to the amount of lost blood and removed chips
is a minimal procedure where no risk of rectal injury or retrograde ejaculation have been reported
it entails making 1 or 2 incisions along all prostate lobes except the apical
IPSS
post void residual
prostate volume
Q-max at uroflowmetry
bladder stones
prostate cancer
renal insufficiency
bladder diverticula
an additional 15 g in prostate weight
each centimeter over the normal 1.5-cm prostate urethral length equates
an additional 5 g in prostate weight
. When comparing suprapubic to retropubic prostatectomy for removing prostatic adenoma, the former allows:
before catheterization
after catheterization and before TURP
immediately after TURP
2 weeks after TURP
PSA > 1.5 ng/dL
prostate volume > 40 ml
IPSS > 19
a & b
calcium channel blockers
antihistamines
antidepressants
cold medications containing pseudoephedrine
urolithiasis
receiving chemotherapy
upper tract surgery
painless hematuria
as a man ages, the responsiveness of prostate cells to androgenic stimuli decreases
adrenal androgens have no role in BPH development
type-1 steroid 5 α-reductase is functionally active in the hair follicle
all of the above
induces nerve degeneration in the prostate and tissue necrosis
frequently results in transient urinary retention
frequently leads to erectile dysfunction
the high-energy platform is superior to the low-energy with regard to clinical efficacy
PVP
HoLEP
HoLRP
TUMT
there is an increase in the number of epithelial and stromal cells
there is an increase in the size of epithelial and stromal cells
in BPH, epithelial to stromal cells ratio is 1:2
all of the above
anterior
median
left lateral
all of the above
intra-prostatic levels of estrogen decrease in men with BPH
stimulation of the adrenergic nervous system results in a dynamic increase in prostatic urethral resistance
inflammation may play a role through cytokines to promote cell growth
hyperplasia occurs due to an imbalance between cell death and cell proliferation
nearly all men have PVR of less than 12 ml
it predicts the outcome of surgical treatment
it correlates well with BPH/LUTS
it is diagnostic for bladder outlet obstruction
enoxaparin
silodosin
finasteride
tolterodine
62 - 78%
48 - 61%
79 - 93%
34 - 47%
cetrorelix
flutamide
dutasteride
zanoterone